111 related articles for article (PubMed ID: 38124264)
1. Validation of a good manufacturing practice procedure for the production of [
Cortés González MA; Högnäsbacka AA; Halldin C; Schou M
J Labelled Comp Radiopharm; 2024 May; 67(6):245-249. PubMed ID: 38124264
[TBL] [Abstract][Full Text] [Related]
2. Development of a fully automated low-pressure [
Ferrat M; El Khoury Y; Larsen P; Dahl K; Halldin C; Schou M
J Labelled Comp Radiopharm; 2020 Oct; 63(12):517-522. PubMed ID: 32588452
[TBL] [Abstract][Full Text] [Related]
3. Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS
Kettle JG; Bagal SK; Barratt D; Bodnarchuk MS; Boyd S; Braybrooke E; Breed J; Cassar DJ; Cosulich S; Davies M; Davies NL; Deng C; Eatherton A; Evans L; Feron LJ; Fillery S; Gleave ES; Goldberg FW; Cortés González MA; Guerot C; Haider A; Harlfinger S; Howells R; Jackson A; Johnström P; Kemmitt PD; Koers A; Kondrashov M; Lamont GM; Lamont S; Lewis HJ; Liu L; Mylrea M; Nash S; Niedbala MJ; Peter A; Phillips C; Pike K; Raubo P; Robb GR; Ross S; Sanders MG; Schou M; Simpson I; Steward O
J Med Chem; 2023 Jul; 66(13):9147-9160. PubMed ID: 37395055
[TBL] [Abstract][Full Text] [Related]
4. Development and Preclinical Evaluation of Radiolabeled Covalent G12C-Specific Inhibitors for Direct Imaging of the Oncogenic KRAS Mutant.
Zhang Z; Wang X; Ye J; Liu H; Fang J; Zhang M; Li Y; Huang J; Zhang D; Wang J; Zhang X
Mol Pharm; 2021 Sep; 18(9):3509-3518. PubMed ID: 34410132
[TBL] [Abstract][Full Text] [Related]
5. Good manufacturing procedure production of [
Dahl K; Larsson S; Bonn P; Wallin A; Itsenko O; Schöll M
J Labelled Comp Radiopharm; 2022 Oct; 65(12):315-322. PubMed ID: 36044030
[TBL] [Abstract][Full Text] [Related]
6. Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [
Luo Z; Gu J; Dennett RC; Gaehle GG; Perlmutter JS; Chen DL; Benzinger TLS; Tu Z
Appl Radiat Isot; 2019 Oct; 152():30-36. PubMed ID: 31280104
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
[TBL] [Abstract][Full Text] [Related]
8. Automated GMP-production of α-[
Nordeman P; Yngve U; Wilking H; Gustavsson SÅ; Eriksson J; Antoni G
J Labelled Comp Radiopharm; 2018 Dec; 61(14):1106-1109. PubMed ID: 29902836
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and validation of [Carboxy-
Holt DP; Kalinda AS; Bambarger LE; Jain SK; Dannals RF
J Labelled Comp Radiopharm; 2019 Jan; 62(1):28-33. PubMed ID: 30089334
[TBL] [Abstract][Full Text] [Related]
10. Alternative strategies for the synthesis of [
Mixdorf JC; Murali D; Xin Y; DiFilippo AH; Aluicio-Sarduy E; Barnhart TE; Engle JW; Ellison PA; Christian BT
Appl Radiat Isot; 2021 Dec; 178():109954. PubMed ID: 34607293
[TBL] [Abstract][Full Text] [Related]
11. An automated radiosynthesis of 2-[11C]thymidine using anhydrous [11C]urea derived from [11C]phosgene.
Steel CJ; Brady F; Luthra SK; Brown G; Khan I; Poole KG; Sergis A; Jones T; Price PM
Appl Radiat Isot; 1999 Oct; 51(4):377-88. PubMed ID: 10464914
[TBL] [Abstract][Full Text] [Related]
12. Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.
Johnström P; Bergman L; Varnäs K; Malmquist J; Halldin C; Farde L
Nucl Med Biol; 2015 Jun; 42(6):555-60. PubMed ID: 25726760
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of [11C]palmitic acid for PET imaging using a single molecular sieve 13X cartridge for reagent trapping, radiolabeling and selective purification.
Amor-Coarasa A; Kelly JM; Babich JW
Nucl Med Biol; 2015 Aug; 42(8):685-90. PubMed ID: 25934348
[TBL] [Abstract][Full Text] [Related]
14. Automated production of
Kaur T; Wright JS; Henderson BD; Godinez J; Shao X; Scott PJH
J Labelled Comp Radiopharm; 2024 May; 67(6):217-226. PubMed ID: 37608567
[TBL] [Abstract][Full Text] [Related]
15. Preliminary PET imaging of [
Boyle AJ; Lindberg A; Tong J; Zhai D; Liu F; Vasdev N
J Labelled Comp Radiopharm; 2024 May; 67(6):235-244. PubMed ID: 37691152
[TBL] [Abstract][Full Text] [Related]
16. Automated two-step manufacturing of [
Caillé F; Gervais P; Auvity S; Coulon C; Marie S; Tournier N; Kuhnast B
Nucl Med Biol; 2020; 84-85():20-27. PubMed ID: 31931306
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of brain tumor with [methyl-11C]choline.
Hara T; Kosaka N; Shinoura N; Kondo T
J Nucl Med; 1997 Jun; 38(6):842-7. PubMed ID: 9189127
[TBL] [Abstract][Full Text] [Related]
18. KRAS Inhibitor Resistance in
Suzuki S; Yonesaka K; Teramura T; Takehara T; Kato R; Sakai H; Haratani K; Tanizaki J; Kawakami H; Hayashi H; Sakai K; Nishio K; Nakagawa K
Clin Cancer Res; 2021 Oct; 27(20):5697-5707. PubMed ID: 34365406
[TBL] [Abstract][Full Text] [Related]
19. [11C]Vinblastine syntheses and preliminary imaging in cancer patients.
Solbach C; Patt M; Reimold M; Blocher A; Dohmen BM; Bares R; Zeller KP; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):266s-276s. PubMed ID: 17718930
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis of the diastereomerically pure (E)-[
Bdair H; Tsai IH; Smart K; Benkelfat C; Leyton M; Kostikov A
J Labelled Comp Radiopharm; 2019 Oct; 62(12):860-864. PubMed ID: 31418468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
